Lower Extremity Arterial Occlusive Disease (LEAOD)

Lower Extremity Arterial Occlusive Disease (LEAOD)

Intermittent Claudication as an Early Warning Sign
Lower Extremity Arterial Occlusive Disease (LEAOD), also known as lower limb atherosclerotic occlusive disease, is a common vascular condition characterized by narrowing or blockage of the arteries supplying the legs due to atherosclerosis. It predominantly affects older adults and is associated with significant morbidity if not diagnosed and treated in a timely manner.
Intermittent Claudication: An Early Symptom Not to Ignore
Many elderly individuals experience calf pain, numbness, or weakness after walking a certain distance. These symptoms typically resolve after a short period of rest but recur when walking resumes. This phenomenon is medically referred to as intermittent claudication and is often an early manifestation of lower extremity arterial occlusion.
Intermittent claudication occurs because narrowed arteries are unable to deliver sufficient blood and oxygen to the leg muscles during activity. Vascular specialists emphasize that this symptom should be taken seriously, as delayed diagnosis may lead to disease progression and inappropriate treatment.
Disease Progression and Clinical Features
Lower extremity arterial occlusive disease is a common and frequently encountered condition in vascular surgery. It is characterized by a long disease course and significant patient discomfort.
• Early and middle stages: Intermittent claudication is the main symptom.
• Advanced stages: As ischemia worsens, patients may develop rest pain, especially at night. The pain can be severe enough to disturb sleep, often forcing patients to bend their knees or massage their feet for relief.
• Late stages: Prolonged and severe ischemia leads to tissue degeneration and necrosis. If infection occurs, inflammation and ischemia reinforce each other, forming a vicious cycle that may ultimately result in limb amputation.
Risk Factors and Epidemiology
LEAOD mainly affects older adults, particularly those with:
• Hypertension
• Hyperlipidemia
• Diabetes mellitus
• A long history of smoking
With improvements in living standards and increasing life expectancy, the incidence of lower extremity arterial occlusive disease has been steadily rising. Early diagnosis and appropriate treatment are crucial for symptom relief, reduction of patient suffering, and prevention of limb loss.
Diagnosis
The diagnosis of LEAOD is relatively straightforward:
• Diminished or absent pedal pulses are the most direct physical signs.
• Duplex ultrasound can accurately identify arterial stenosis or occlusion.
• Contrast-enhanced CT angiography (CTA) provides a clear visualization of the location, severity, and extent of vascular lesions.
Treatment Strategies
Management of lower extremity arterial occlusive disease includes conservative therapy and surgical or endovascular intervention, depending on the severity of ischemia.
Conservative Treatment
For patients with mild ischemia, a claudication distance greater than 200 meters, and no tissue necrosis, conservative management is often effective. Key measures include:
• Smoking cessation
• Keeping the limbs warm
• Avoiding trauma
• Structured exercise therapy
• Medical treatment, such as antihypertensive agents, lipid-lowering drugs, antiplatelet therapy, and vasodilators
Surgical and Endovascular Treatment
For patients with severe ischemic symptoms, including:
• Claudication distance less than 200 meters
• Rest pain
• Distal tissue necrosis
Timely surgical or endovascular intervention is strongly recommended to restore blood flow to the affected limb. Treatment options include:
• Bypass surgery using synthetic grafts or autologous great saphenous vein
• Endovascular therapies such as balloon angioplasty and stent placement
When appropriate surgical intervention is combined with optimized conservative treatment, most patients experience sustained symptom relief and significant improvement in quality of life.
Conclusion
Lower extremity arterial occlusive disease is a progressive but treatable condition. Recognizing intermittent claudication as an early warning sign and seeking timely vascular evaluation can prevent disease progression, reduce the risk of amputation, and significantly improve patient outcomes.